Top Markets
Coin of the day
Cell MedX Corp. Cell MedX Corp.

Cell MedX Corp.

CMXC
Rangering i aksjer #30404
Cell MedX Corp. is a biotechnology firm dedicated to identifying, developing,... Cell MedX Corp. is a biotechnology firm dedicated to identifying, developing, and marketing both therapeutic and non-therapeutic solutions aimed at individuals suffering from conditions such as diabetes, Parkinson's disease, hypertension, neuropathy, and various kidney-related ailments. The company's offerings include the eBalance Pro System, designed for clinical application by medical professionals, and the eBalance Home System, intended for personal use to promote general well-being and alleviate pain. Both systems are managed by the eBalance Console, a central control unit featuring three distinct pre-programmed microcurrent algorithms: wellness, pain management, and a dual mode. Originally established in 2010 as Sports Asylum, Inc., the company adopted its current name, Cell MedX Corp., in September 2014. Its operations are headquartered in Carson City, Nevada.
Aksjekurs
$0.41
Sist synkronisert: 2024-12-24
Markedsverdi
$16.96M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Cell MedX Corp. (CMXC)

Kategori

Pris CMXC pris med markedsverdi på B
Cell MedX Corp. Cell MedX Corp.
CMXC
$0.41
Markedsverdi av Cell MedX Corp.(CMXC)
Markedsverdi: $16.96M
Per August 2026 har Cell MedX Corp. en markedsverdi på $16.96M. Dette gjør Cell MedX Corp. til det 30404th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Cell MedX Corp. fra 2013 til 2026
CMXC sammenlignet med topp 5 mest populære stocks
Pris på CMXC Eiendel B Markedsverdi for B Resultater
Cell MedX Corp. Cell MedX Corp.
$128,272 $16.96M
$5.307T +31,285,805.23%
Cell MedX Corp. Cell MedX Corp.
$110,002 $16.96M
$4.551T +26,829,562.73%
Cell MedX Corp. Cell MedX Corp.
$100,420 $16.96M
$4.154T +24,492,701.23%
Cell MedX Corp. Cell MedX Corp.
$86,743.40 $16.96M
$3.589T +21,156,826.18%
Cell MedX Corp. Cell MedX Corp.
$67,606.20 $16.96M
$2.797T +16,489,216.79%